This page shows only what two FDA drug labels say about each other. Each quote below is copied word for word from label text stored by OmniRx; table rows are shown as extracted, so column text can run together.
Duloxetine label names tramadol
Serotonin Syndrome The development of a potentially life-threatening serotonin syndrome has been reported with SNRIs and SSRIs, including duloxetine delayed-release capsules, alone but particularly with concomitant use of serotonergic drugs (including triptans, tricyclic antidepressants, fentanyl, lithium, tramadol, tryptophan, buspirone, amphetamines, and St. John’s Wort) and with drugs that impair metabolism of serotonin (in particular, MAOIs, both those intended to treat psychiatric disorders and also others, such as linezolid and intravenous methylene blue).
05a744a5-64ef-42d7-a19c-568be5a272d4, version 6, effective 2026-04-22. Open on DailyMed. Named in 14 of 14 labels read for this ingredient.Tramadol label names a drug class that FDA also assigns to duloxetine
FDA's own class record for duloxetine: Norepinephrine Uptake Inhibitors [MoA]; Serotonin Uptake Inhibitors [MoA]; Serotonin and Norepinephrine Reuptake Inhibitor [EPC]. Sources: NLM RxClass. This product uses publicly available data from the U.S. National Library of Medicine (NLM). Whether the class statement below applies to duloxetine depends on the label's own wording.
Increased Risk of Seizures : Present within recommended dosage range. Risk is increased with higher than recommended doses and concomitant use of SSRIs, SNRIs, anorectics, tricyclic antidepressants and other tricyclic compounds, other opioids, MAOIs, neuroleptics, other drugs that reduce seizure threshold, in patients with epilepsy or at risk for seizures.
004de5a4-80f8-4040-a6ea-be5e99352a36, version 24, effective 2025-11-20. Open on DailyMed.Cases of serotonin syndrome, a potentially life-threatening condition, have been reported with the use of tramadol products, including tramadol hydrochloride extended-release tablets, particularly during concomitant use with serotonergic drugs. Serotonergic drugs include selective serotonin reuptake inhibitors (SSRIs), serotonin and norepinephrine reuptake inhibitors (SNRIs), tricyclic antidepressants (TCAs), triptans
004de5a4-80f8-4040-a6ea-be5e99352a36, version 24, effective 2025-11-20. Open on DailyMed.Serotonergic Drugs Clinical Impact: The concomitant use of opioids with other drugs that affect the serotonergic neurotransmitter system has resulted in serotonin syndrome [see Warnings and Precautions (5.9) ]. Intervention: If concomitant use is warranted, frequently evaluate the patient, particularly during treatment initiation and dose adjustment. Discontinue tramadol hydrochloride extended-release tablets if serotonin syndrome is suspected. Examples: Selective serotonin reuptake inhibitors (SSRIs), serotonin and norepinephrine reuptake inhibitors (SNRIs)
004de5a4-80f8-4040-a6ea-be5e99352a36, version 24, effective 2025-11-20. Open on DailyMed.What this page does not cover
OmniRx has not extracted a passage from the tramadol labels that names duloxetine. That means only that none is shown here. The tramadol labels may say more, so read the full current labels on DailyMed.
Where this comes from
FDA drug label text via openFDA (public domain), US labels only, stored in OmniRx edition 2026-11 (root 98912c55a72b), read on 2026-11-13. A passage here is a record that a label names a drug, not a finding that the two interact. Ask your pharmacist or prescriber about your own medicines, and do not start, stop or change a medicine because of anything on this site.